arrow
A

Anita Gąsiorowska

Medical University of Lodz
H指数:23
被引数:1,839

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease

波兰中重度溃疡性结肠炎或克罗恩病患者在 vedolizumab 诱导治疗期间的临床应答及生活质量、疲劳、情绪和睡眠障碍的改善

2026-06-020
OA
Real-world utility of platelet count, hemoglobin, and iron levels as predictors of clinical response to vedolizumab in patients with ulcerative colitis: a retrospective, single-center study in Poland

血小板计数、血红蛋白和铁水平的实际应用价值及其作为溃疡性结肠炎患者对 Vedolizumab 临床反应预测指标的研究:一项来自波兰的单中心回顾性研究

2026-04-020
OAAI
Multi-Strain Probiotic Improves Tryptophan Metabolism and Symptoms in Chronic Fatigue Syndrome Patients with Co-Occurring Irritable Bowel Syndrome: An Open-Label Pilot Study

多菌株益生菌改善慢性疲劳综合征合并肠易激综合征患者的色氨酸代谢和症状:一项开放标签的初步研究

2026-01-060
OAAI
Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational Study
2025-03-010
OA
Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome-A Randomized, Double-Blind, Placebo-Controlled Study
2024-12-240
OAAI
Discharge protocol in acute pancreatitis: an international survey and cohort analysis

急性胰腺炎出院规范:一项国际调查与队列分析

2023-12-136
OAAI
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)
2021-08-306
OAAI